Driving research of Myalgic Encephalomyelitis / Chronic Fatigue Syndrome (ME / CFS),
Post Treatment Lyme Disease Syndrome (PTLDS), Fibromyalgia and Long Covid

A Gift for May Awareness Month 2014

$227,000 Sunshine Project Grant for Gene Expression and Cell Separation Equipment.

Affymetrix System
Humans have tens of thousands of genes, and Microarrays Chip with 70,000+ genes will make it possible to examine the expression of these genes at once taking a small volume of blood or tissue from patients.  Microarrays are one of the key tools in genomic research, allowing researchers to identify specific subtypes within an overall disease category based on differences in gene expression.
Physicians and researchers are beginning to use information from microarrays to determine profiles relevant to diagnosis and treatment and ultimately which will most likely yield beneficial results for particular patients.
For example, today as a result of the microarray, testing for elevated expression of certain genes can assist in predicting cancer outcomes, and in assigning appropriate treatment programs. Microarray technology has also been used widely to examine global gene-expression changes in disease, thereby shedding additional light on the complex nature of many conditions.

Robosep
Normally, 7-8% of human body weight is from blood.  Blood is a highly specialized tissue composed of more than 4,000 different kinds of components.  Four of the most important ones are red cells, white cells, platelets, and plasma. Robosep helps in isolating different cells types with 98% purity. Different cell types can then be isolated in subtypes for example, white blood cells have natural killer cells (NK cells) (which function in cell-mediated, cytotoxic innate immunity), T cells (for cell-mediated, cytotoxic adaptive immunity), and B cells (for humoralantibody-driven adaptive immunity) and Monocytes. Analysis of these cells would help in understanding the immune system and designing therapies based on the needs of the patients.
Robosep would empower us to isolate these and other cell types and perform different assays, which would help in immunologic research, drug discovery and development. We can also develop the cell based assays and see the expression of different genes in each cell type, using microarray chip technology.
OMI is working towards finding markers for lesser known diseases, as Myalgic Encephalomyelitis, Chronic Fatigue Syndrome, Lyme and others which are hard to diagnose. This tool will help physicians in characterizing and understanding the patient’s conditions better and treat patients not just according to their symptoms, but also according to their molecular makeup and based on their gene expression data.

Myalgic Encephalomyelitis / Chronic Fatigue Syndrome (ME / CFS) Post Treatment Lyme Disease Syndrome (PTLDS), Fibromyalgia Leading Research. Delivering Hope.Open Medicine Foundation®

What are the advantages of giving from your Donor Advised Fund (DAF)?

  • Your gifts to your donor advised fund entitle you to an immediate income tax deduction at the time of contribution.
  • You avoid capital gains tax on appreciated assets you place in your donor advised fund.
  • Your fund’s investment gains accumulate tax free.
  • Funds are distributed to Open Medicine Foundation in your name and immediately put to use to support our worldwide research efforts.

How do I make a donation through my DAF?

Just click on the DAF widget below. It is simple and convenient to find your fund among the over 900 funds in our system.

Still can’t find your fund? 

  • Request a grant distribution through your Donor Advised Fund sponsor
  • Be sure to use OMF’s EIN #26-4712664
  • You can also designate OMF as a beneficiary for your Donor Advised Fund
  • Questions? Give us a call at 650-242-8669